Pharmaceuticals and Biotechnology Litigation
In this Jan-Mar 2023 issue of Corporate Disputes e-magazine, Sean Sheridan, along with other industry professionals, discusses significant developments shaping...
This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.
Whether working on behalf of plaintiff or defendant, CRA’s experts provide objective, data-driven analyses that capture the true economic impact of patent infringement. Companies and counsel rely on our experts in all phases of litigation, including pre-complaint damages analysis, discovery to develop defensible damages theories, expert damages reports, and at trial. CRA experts provide well-supported opinions on lost profits and reasonable royalty damages considering the impact of non-infringing alternatives, prior transactions, profitability and apportionment. Our extensive trial experience results in clear and compelling testimony to the trier of fact.
In this Jan-Mar 2023 issue of Corporate Disputes e-magazine, Sean Sheridan, along with other industry professionals, discusses significant developments shaping...
Among the pieces featured in this month’s IP Literature Watch are a paper discussing the licensing of 5G SEPs by automotive manufacturers; an essay exposing...